Učitavanje...

Risk Factors for Delayed Elimination of Methotrexate in Children, Adolescents and Young Adults With Osteosarcoma

Background/Aim: High-dose methotrexate (HD-MTX) is pivotal chemotherapy in the treatment of patients with osteosarcoma. Blood concentrations of MTX are associated with several side effects, but there are large individual differences in the elimination of MTX. The aim of this study was to explore ris...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:In Vivo
Glavni autori: MISAKA, KO, SUGA, YUKIO, STAUB, YUKIKO, TSUBATA, ATSUMI, SHIMADA, TSUTOMU, SAI, YOSHIMICHI, MATSUSHITA, RYO
Format: Artigo
Jezik:Inglês
Izdano: International Institute of Anticancer Research 2020
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7811654/
https://ncbi.nlm.nih.gov/pubmed/33144454
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.12185
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!